【正文】
:86S91S.5 Malfertheiner P,Peitz U,Treiber constitutes failure for Helicobacter pylori eradication therapy?Can J Gastroenterol,2003,17(Suppl B):5357. 7 Georgopoulos SD,Ladas SD,Karatapanis S,et that may affect treatment oute of triple Helicobacter pylor eradication therapy with omeprazole,amoxicillin,and Dis Sci,2000,45:6367. 9 Houben MHM,Van Beek D,Tytgat systematic review of Helicobacter pylori eradication therapythe impact of antimicrobial resistance on eradication Pharmacol Ther,1999,13:1047. 11 Yakoob J,F(xiàn)an X,Hu G,et susceptibility of Helicobacter pylori in the Chinese Gastroenterol Hepatol,2001,16:981985. 13 Ducons JA,Santolaria S,Guirao of clarithromycin resistance on the effectiveness of a regimen for the Helicobacter pylori:a prospective study of 1 week lansoprazole,amoxicillin and clarithromycin in active peptic Pharmacol Ther,1999,13:775780. 15 胡品津,李瑜元,陳湖,、1997,17:204206. 17 華志民,王崢,周軼,2002,1:3435. 19 Malfertheiner P,Megraud F,O’Morain C,et Helicobacter pylori study Group (EHPSG).Current concepts in the management of Helicobacter pylori infectionthe Maastricht 22000 Consensus Pharmacol Ther,2002,16:167180. 21中國(guó)).中華醫(yī)學(xué)雜志,2004,84(6):522. 22 Laine it time for quadruple therapy to be first line?Can J Gastroenterol,2003,17(Suppl B):3335.24 Fairman KA,Motheral decisionanalytic models identify costeffective treatments?A retrospective look at Helicobacter pylori Manag Care Pharm,2003,9:430440. 26 鄭惠虹,2000,10(5):270271. 2816